GMO Emerging Markets Opportunities III
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | Diversified Emerging Mkts | | Fund Family: | GMO | | Net Assets: | 179.86M | | Year-to-Date Return: | -11.27% | | Yield: | 2.57% | | Morningstar Rating: |  | | Fund Inception Date: | 18-Feb-98 |
|
Arjun Divecha
Lead Manager since
18-Feb-98 | | | Divecha is director of Emerging Markets Division at GMO. Divecha has been responsible for overseeing the portfolio management of GMOs emerging markets equity portfolios since 1993. Prior to 2001, Divecha provided these services through Dancing Elephant, Ltd., which had been engaged by GMO to provide consulting services to GMO with respect to those portfolios. |
| Min Initial Investment: | $10,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks high total return. The fund invests primarily in equity securities of companies traded in Asia, Latin America, the Middle East, Africa and Europe. The manager uses proprietary quality models to evaluate an issuer's quality score. The fund's allocation to emerging market countries may be over or under weighted with respect to the benchmark. The fund invests at least 80% of net assets plus any borrowings made for investment purposes in investments tied economically to emerging markets. The fund is nondiversified. |
| Last Dividend
(24-Jul-08):
| 0.08 | | Last Cap Gain
(24-Jul-08):
| 4.24 | | Annual Holdings Turnover
| 17.00% | | Average for Category:
| 78.31% |
|
| Expense | GMASX | Category
Avg | | Total Expense Ratio: | 0.71%
| 1.77% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.30% | | Max Deferred Sales Load: | 0.00%
| 2.46% | | 3 Yr Expense Projection*: |
$333 | $731 | | 5 Yr Expense Projection*: |
$508 | $1,156 | | 10 Yr Expense Projection*: |
$1,014 | $2,302 |
|
|
1.47% Nasdaq 
Profile
